GHCM
RGNX icon

Glen Harbor Capital Management’s Regenxbio RGNX Stock Holding History

Glen Harbor Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$284K Buy
7,990
+578
+8% +$23.4K 0.01% 901
2019
Q2 		$381K Hold
7,412
– – 0.01% 798
2019
Q1 		$425K Buy
7,412
+476
+7% +$23.6K 0.01% 740
2018
Q4 		$291K Buy
6,936
+1,258
+22% +$73.8K 0.01% 824
2018
Q3 		$429K Buy
5,678
+3,298
+139% +$238K 0.01% 782
2018
Q2 		$171K Buy
+2,380
New +$114K ﹤0.01% 1021

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Glen Harbor Capital Management's RGNX Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Regenxbio (RGNX) stake by 7.8% in Q3 2019, buying an estimated $23.4K and bringing the position to 7,990 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #901.

Glen Harbor Capital Management first reported a position in RGNX in Q2 2018 and has held it in 6 quarters since. The position peaked at $429K in Q3 2018. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

  • Glen Harbor Capital Management held 7,990 shares of Regenxbio worth $284K as of Q3 2019.
  • Glen Harbor Capital Management bought 578 Regenxbio shares in Q3 2019, an estimated $23.4K.
  • Regenxbio made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #901 holding.
  • Glen Harbor Capital Management first reported a position in Regenxbio in Q2 2018 and has held it in 6 quarters since.
  • Glen Harbor Capital Management's Regenxbio position peaked at $429K in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.